ASM Microbe: GeoVax present single-dose vaccines for Ebola, Lassa and Zika

0
At ASM Microbe (7–11 June, Atlanta, GA, USA) researchers from GeoVax (GA, USA) have presented their flexible ‘Plug and Play’ platform technology that could deliver a single-dose vaccine to fully protect against key emerging diseases.

“Unlike other vaccine technologies currently available, which sacrifice confidence in success for speed or vice-versa, the GeoVax technology offers a true ‘Plug and Play’ platform approach that is well suited for use against a wide range of biological threats and amenable to rapid, large-scale production,” commented Rahul Basu, a scientist at GeoVax.

To view restricted content, please:
Share:

Leave A Comment